ArticleAbdominal radiology (New York)2026
Artificial intelligence-based segmentation of small renal masses: a multi-center, multi-scanner, multi-sequence study.
Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Deep learning-based segmentation and detection of focal liver lesions on multi-sequence non-contrast MRI.Abdominal radiology (New York) · 2026Article
- Artificial Intelligence in the Detection, Characterization, and Management of Renal Masses: A Narrative Review.Cureus · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
Abstract
objectivesThis study aims to develop an artificial intelligence (AI)-based automated segmentation method for small renal masses (SRMs) using multi-center, multi-scanner, multi-sequence MRI data.
methodsMR images from 988 pathologically confirmed SRM patients from three different centers were retrospectively included. Segmentation networks were independently developed for each MRI sequence using deep learning techniques. A GE dataset of 733 patients from Center 1 was used for training and validation. A GE test set, consisting of internal (99 from Center 1) and external test sets (81 from Center 2 and 3), was created for evaluation. Furthermore, a non-GE generalization set, consisting of 75 patients from Center 2 and 3, was used to assess the generalization ability. The method's performance was evaluated in terms of detection rate and segmentation accuracy (Dice similarity coefficient [DSC]). Subgroup analysis and multiple linear regression were used for further exploration.
resultsOur method demonstrated promising results in the detection and segmentation of SRMs. All patients in the GE test set were correctly detected in at least one sequence. Our model achieved a median DSC of 0.769-0.855 across five MRI sequences and demonstrated reasonable generalization to non-GE scanners (median DSC range: 0.523-0.785).
conclusionsThe implementation of automated segmentation achieved encouraging outcomes in both correct-detection rates and segmentation accuracy across a diverse cohort spanning multiple centers and scanners, suggesting its potential as a key component of future diagnostic pipelines for SRMs.
Indexed as
Identifiers
41171407What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.